Cwm, LLC Arbutus Biopharma Corp Transaction History

Cwm, LLC

  • $24.1 Billion
  • Q4 2024

A detailed history of Cwm, LLC transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Cwm, LLC holds 2,438 shares of ABUS stock, worth $8,216. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,438
Previous 2,500 2.48%
Holding current value
$8,216
Previous $10,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025
SELL
$3.18 - $4.2 $197 - $260
-62 Reduced 2.48%
2,438 $8,000
Q3 2024

Oct 08, 2024
BUY
$3.12 - $4.56 $502 - $734
161 Added 6.88%
2,500 $10,000
Q2 2024

Jul 09, 2024
BUY
$2.52 - $3.63 $1,617 - $2,330
642 Added 37.83%
2,339 $7,000
Q1 2024

Apr 05, 2024
BUY
$2.26 - $2.92 $3,512 - $4,537
1,554 Added 1086.71%
1,697 $4,000
Q4 2023

Feb 01, 2024
BUY
$1.69 - $2.54 $224 - $337
133 Added 1330.0%
143 $0
Q3 2020

Sep 15, 2021
BUY
$1.75 - $6.2 $17 - $62
10 New
10 $0
Q3 2020

Oct 19, 2020
SELL
$1.75 - $6.2 $17 - $62
-10 Closed
0 $0
Q2 2020

Sep 15, 2021
BUY
$0.91 - $2.36 $9 - $23
10 New
10 $0
Q2 2020

Jul 22, 2020
SELL
$0.91 - $2.36 $9 - $23
-10 Closed
0 $0
Q1 2020

Sep 15, 2021
BUY
$1.01 - $3.42 $10 - $34
10 New
10 $0
Q1 2020

Apr 28, 2020
SELL
$1.01 - $3.42 $10 - $34
-10 Closed
0 $0
Q4 2019

Sep 14, 2021
BUY
$0.87 - $2.89 $8 - $28
10 New
10 $0
Q4 2019

Jan 27, 2020
SELL
$0.87 - $2.89 $8 - $28
-10 Closed
0 $0
Q3 2019

Sep 14, 2021
BUY
$1.34 - $2.4 $13 - $24
10 New
10 $0
Q3 2019

Oct 22, 2019
SELL
$1.34 - $2.4 $13 - $24
-10 Closed
0 $0
Q2 2019

Sep 14, 2021
BUY
$1.46 - $4.44 $14 - $44
10 New
10 $0
Q2 2019

Jul 31, 2019
SELL
$1.46 - $4.44 $14 - $44
-10 Closed
0 $0
Q1 2019

Sep 02, 2021
BUY
$3.41 - $4.57 $34 - $45
10 New
10 $0

Others Institutions Holding ABUS

# of Institutions
165
Shares Held
102M
Call Options Held
649K
Put Options Held
666K
View Full List

About Arbutus Biopharma Corp

ABUS Quotes by TradingView
  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $505M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email